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A b s t r a c t
Orbital diseases may be divided into congenital defects of the orbit, infectious and inflammatory diseases, orbital 
tumors (including malignant and benign tumors) and injuries. Idiopathic inflammatory syndromes are often encoun-
tered within the orbit and are usually classified as orbital pseudotumors. The etiology of pseudotumors of the vision 
organ is unknown. Infectious agents, autoimmune disorders and improper healing are taken into consideration in 
the pathogenesis of this disorder. Thanks to detailed studies conducted in recent years, a new disease syndrome was 
identified in 2001. It is known as IgG4-related disease, and its differentiation is based on the analysis of IgG4 levels 
in the affected tissues. Orbital locations of the disease were first reported in Japan as late as at the end of 2009. 
This finding triggered the European studies on this subject. To date, no such studies have been conducted in Poland. 
The starting study population consisted of 167 patients with isolated infiltrative tumor diseases within the orbital 
region treated at the Department of Otolaryngology, Head and Neck Surgery of the Medical College Jagiellonian 
University in Krakow. Detailed analysis and diagnostic screening for IgG4-related disease was performed in a total of 
17 patients diagnosed with orbital pseudotumor.
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Introduction
Orbital diseases may be divided into congenital 
defects of the orbit, infectious and inflammatory dis-
eases, injuries and tumors, including malignant and 
benign tumors. The diseases may either originate at 
orbital structures, or be due to continuous spread 
of the pathological process from adjacent tissues, 
or constitute distant metastases as well as symp-
toms of a  systemic disease. The variety of tumors 
observed within the orbit is due to its complex devel-
opment and structure [21]. 
Idiopathic inflammatory syndromes are often 
en countered within the orbit and are usually classi-
fied as orbital pseudotumors. Usually, inflammatory 
orbital pseudotumors are represented as non-granu-
lomatous inflammatory processes in the orbit or the 
eyeball, with unknown local or systemic etiology. In 
most cases, the diagnosis is made on the basis of 
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the interview, clinical presentation, response to ste-
roid treatment and the results of laboratory inves-
tigations and biopsies. The clinical presentation of 
pseudotumors is very diverse and may resemble 
numerous other diseases, such as lymphoma, sar-
coidosis, fibromatosis, or systemic connective tis-
sue disorders [22]. Pseudotumors should exclude 
inflammations due to Wegener’s granulomatosis, 
persistent foreign bodies, sclerosing hemangiomas, 
complications of injuries and inflammation of para-
nasal sinuses. Pseudotumors are the most common 
orbital disorder in adults after Graves’ orbitopathy; 
their incidence is estimated at 4.7-6.3% of all orbital 
diseases [27]. Bilateral location of pseudotumors in 
adult patients may suggest the presence of a gen-
eralized disease such as generalized vasculitis or 
generalized lymphoid hyperplasia. Patients suffer-
ing from pseudotumors often complain of acute 
pain located within the orbit, limited mobility of the 
eyeball, eyeball protrusion and impaired acuity of 
vision. Conjunctival hyperemia, eyelid swelling and 
redness and excessive lacrimation are also common. 
Pseudotumors may affect various orbital structures, 
such as muscles, adipose tissue or lacrimal glands. 
The etiology of pseudotumors of the vision organ is 
unknown. Infectious agents, autoimmune disorders 
and improper healing are taken into consideration 
in the pathogenesis of this disorder. Macroscopical-
ly, orbital pseudotumors are most commonly solid, 
well-differentiated masses of yellow/gray or pink/
gray color. Inflammatory pseudotumors are com-
monly multifocal and may cause inflammation of 
extraorbital muscles, lacrimal tracts, Tenon’s capsule 
and cerebral meninges surrounding the optic nerve 
and the adjacent tissues [35].
Thanks to detailed studies conducted in recent 
years, a  new disease syndrome was identified in 
2001. It is known as IgG4-related disease, and its dif-
ferentiation is based on the analysis of IgG4 levels in 
the affected tissues [39]. Orbital locations of the dis-
ease were first reported in Japan as late as at the end 
of 2009. This finding triggered the European studies 
on this subject. To date, no such studies have been 
conducted in Poland. It has been established that 
IgG4-related orbital disease is a  recently defined 
inflammatory process that is characterized by 
1) inflammatory infiltration of IgG4-producing plas-
ma cells; 2) tendency to form tumorous lesions at dif-
ferent sites; 3) increased serum IgG4 levels, although 
this is not a  required condition [22]. IgG4-related 
disease is considered to be a  generalized process 
involving a wide spectrum of various diseases that 
may affect distant organs. Particular progress was 
made recently due to in-depth clinical and patholog-
ical studies of diseases suspected of being depen-
dent on increased levels of IgG4-positive plasma 
cells [27]. This type of lesion has been observed in 
a variety of organs, such as pancreas, hepatobiliary 
duct, salivary glands, orbits, lymph nodes, retro-
peritoneal space, kidneys, lungs, skin, and aorta. It 
is difficult to estimate the incidence rate of IgG4- 
related diseases due to the relatively low awareness 
of the possibility of this disease among physicians. 
The most reliable data originating from Japan esti-
mate the incidence rate of IgG4-related disease to 
be 0.28-1.08 cases per 100 000 individuals [30].
Clinical experiments on primary, isolated orbital 
tumors show that they remain difficult to diagnose 
and treat for physicians of different specialties; we 
decided to address this issue in light of the recent 
establishment of IgG4-related disease as a  new 
nosocomial entity. Orbital IgG4-related disease is 
a recently reported issue that may prove important 
for elucidation of the etiology of idiopathic, lymph-
oplasmacytic or fibrotic disorders of various organs, 
including the orbits. The goal of this study is to facil-
itate the diagnostic procedures in the treatment 
of patients with non-neoplastic, primary, isolated 
tumors, excluding eyeball tumors, metastatic tumors 
and tumors infiltrating from adjacent tissues, includ-
ing from the nose and paranasal sinuses. Detailed 
assessments were performed in a group of patients 
diagnosed with orbital pseudotumors in the clini-
cal material of the Otorhinolaryngological Clinic of 
the Jagiellonian University Medical College over the 
last 11 years. The usefulness of immunohistochem-
ical diagnostics in correct diagnosis of IgG4-related 
orbital disease was studied. 
Material and methods
The study was undertaken to facilitate the diag-
nostics and treatment of patients with non-neo-
plastic, primary, isolated tumors, excluding eyeball 
tumors, metastatic tumors and tumors infiltrating 
from adjacent tissues, including from the nose and 
paranasal sinuses. Detailed, retrospective assess-
ments were performed in a group of patients with 
isolated orbital diseases in the clinical material of 
the Otorhinolaryngological Clinic of the Jagiellonian 
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University Medical College in the years 2002-2012. 
All the experiments reported in this manuscript were 
conducted in accordance with the local ethics com-
mittee of Medical College Jagiellonian University, 
Krakow, Poland. The usefulness of immunohisto-
chemical diagnostics in correct diagnosis of IgG4- 
related orbital disease was studied. The study was 
conducted in a group of patients qualified for radical 
procedures or biopsies (often without initial histo-
pathological diagnosis). Patients with a  history of 
previous surgery, radiation therapy and corticoste-
roid treatment in relation to the vision organ were 
excluded from the study. All specimens archived 
at the Chair of Pathomorphology of the Jagiellonian 
University Medical College in Krakow were subject- 
ed to histopathological examination. At the first 
stage, 17 cases of orbital pseudotumors were select-
ed from histological specimens subjected to routine 
HE stain. 
Immunohistochemical assays were carried out 
in a  standard manner [31,32]. The assessment of 
eosinophils and neutrophils was carried out by 
means of HE staining, while quantitation of plas-
ma cells was achieved by using murine monoclonal 
anti-CD138 antibodies (DakoCytomation, Denmark, 
1 : 100, 30 min, citrate buffer). IgG levels were deter-
mined using rabbit polyclonal antibodies (Dako-
Cytomation, Denmark, 1 : 800, 30 min proteinase K 
unmasking), while IgG4 levels were determined 
using rabbit monoclonal antibodies (Aabcam, 1 : 300, 
30 min, citrate buffer). Visualization of the anti-
gen-antibody complex was achieved using the Ultra 
Vision LP Value Detection System (LabVision Corp.) 
with 3,3’-diaminobenzidine (DAB) tetrahydrochlo-
ride (DAKO Corp.) chromogen kit. Cell nuclei were 
contrasted using Mayer’s hematoxylin for 1 minute 
and then covered by cover glasses in Cytoseal XYL 
(Thermo SCIENTIFIC). Microscopic specimens were 
assessed using Olympus CX41 and Nikon Eclipse 50i 
microscopes.
In each case, guidelines [32] were followed by 
searching for three sites with the highest number 
of IgG4+ plasma cells and assessing the number of 
these cells at these sites at 40x magnification. Next, 
total plasma cell counts and IgG-producing plasma 
cell counts were assessed in identical areas in sam-
ples assayed for IgG and CD138. Routinely stained 
specimens were assessed for fibrosis, other infiltra-
tions within the lesion (infiltrations of acidophils 
and neutrophils as well as lymphoplasmacytic infil-
tration with or without formation of follicles) and 
vascular lesions manifested as wall thickening and 
lumen narrowing. All these lesions were assessed 
by semiquantitative methods (1+: small lesions; 
2+: medium lesions; 3+: advanced lesions). Immuno-
histochemical assays using anti-IgG, anti-IgG4 and 
anti-CD138 antibodies were used to estimate the 
IgG4+/CD138+ and IgG4+/IgG+ ratios. 
Results
Of the group of isolated orbital tumors, con-
sisting of 167 patients, patients diagnosed with 
malignant tumors on the basis of postoperation-
al histopathological assessment were excluded. 
A total of 116 remaining patients were included in 
the selected study group on the basis of postoper-
ational histopathological assessment. Histopatho-
logical diagnoses included pseudotumor, vascular 
malformations, cavernous angioma, arterial angio-
ma, dermoid cyst with inflammatory infiltration, 
mixed tumor of the lacrimal gland, inverted papillo-
ma, neurinoma, neurofibroma, meningioma, and 
adi poma. Detailed analysis and diagnostic screening 
for IgG4-related disease was performed in a  total 
of 17 patients diagnosed with orbital pseudotu-
mor. The mean age at diagnosis was 49.65 years. 
The analysis of tumor locations in patients diag-
nosed with orbital pseudotumor revealed antero-
equatorial location in 7 cases and retroequatorial 
location in 10 patients. Pseudotumors were located 
within the right orbit in 7 patients and within the 
left orbit in 9 patient. In one patient, pseudotumors 
were located in both orbits. A  similar incidence of 
the tumor was observed in both genders (Fig. 1A); 
no significant differences were observed in relation 
to the affected orbit side (Fig. 1B).
A  detailed analysis of histopathological lesions 
(Table I) in patients diagnosed with orbital pseudo-
tumors revealed changes in the IgG4+/CD138+ and 
IgG4+/IgG+ ratios in patients subjected to immu-
nohistochemical diagnostic screening for IgG4-re-
lated disease. Extensive vascular lesions with wall 
thickening and lumen narrowing were observed in 
all patients; the IgG4+/CD138+ ratio was higher than 
10% in all cases. The mean IgG4+/CD138+ ratio was 
32.4% (Fig. 2A). The results were obtained by calcu-
lating the IgG4+/IgG+ ratio, usually exceeding 40%, 
and more than 80% in 3 patients. The mean IgG4+/
IgG+ ratio was 53.5% (Fig. 2B). Most histopathological 
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specimens featured follicles and lacrimal gland tis-
sue. Table I presents the lack of correlation between 
the IgG4+/CD138+ and IgG4+/IgG+ ratios de pending 
on the age and gender of patients. 
Table II presents a  detailed analysis of histo-
pathological lesions in patients with histopatholog-
ical diagnosis of orbital pseudotumor subjected to 
immunohistochemical screening for IgG4-related 
disease. The following lesions were observed in his-
topathological examinations of operated patients: 
extensive fibrosis – mean grade of 2.67 (scale 0-3), 
numerous plasma cell infiltrations – 2.05 (scale 0-3), 
eosinophilic infiltrations of grade up to 1.5 (scale 
0-3), i.e. as many as 20-25 cells in certain fields under 
large magnification (40x); in most cases only isolat-
ed neutrophils – 0.18 (scale 0-3), vascular lesions 
(wall thickening and stenosis of tiny vessels of dif-
ferent intensity) in all cases as well as inflammato-
ry thrombotic lesions in 3 cases; the IgG4+/CD138+ 
ratio was always more than 10%, 32.3% on average, 
while the IgG4+/IgG+ was above 40% in all cases, and 
more than 80% in 3 patients (ca. 53.5% on average) 
(Table II). In all cases, fragments of lacrimal gland tis-
sue and follicles were present in all histopathological 
specimens. Figure 3 presents a  typical image of an 
inflammatory orbital pseudotumor. Profuse lympho-
plasmacytic infiltration of fibrous tissue, and CD138+ 
plasma cells are visible. The IgG+ reaction seems to 
be present in a  larger number of cells compared to 
the CD138+ reaction. However, it should be noted 
that IgG may also be produced by some of the B lym-
phocytes differentiating into plasma cells. What is 
interesting, nearly all immunohistochemistry-marked 
plasma cells (CD138+) are IgG4-positive. 
Discussion
Reports of possible incidence of IgG4-related 
disease were published in late 2001. The first suspi-
Fig. 1. A) Comparison of incidence of pseudotumors within the right or left orbit. B) Comparison of incidence 
of pseudotumors in females and males.
Table I. Detailed analysis of age, gender and 
tumor location in patients with histopatholo-
gical diagnosis of orbital pseudotumor subject- 
ed to immunohistochemical screening for IgG4- 
related disease
Pseudotumor – IgG4+-related
n Sex Age IgG4+/CD138+ IgG4+/IgG+
1 F 41 > 20% > 40%
2 F 44 > 40% > 60%
3 F 67 > 20% > 50%
4 M 52 > 30% > 50%
5 M 17 > 20% > 40%
6 M 18 > 20% > 50%
7 M 54 > 40% > 60%
8 F 75 > 10% > 40%
9 M 41 > 80% > 80%
10 F 40 > 50% > 50%
11 M 62 > 10% > 40%
12 F 32 > 20% > 40%
13 F 79 > 10% > 40%
14 F 50 > 40% > 60%
15 M 55 > 80% > 80%
16 M 66 > 20% > 50%
17 M 51 > 40% > 80%
F – female, M – male
Left  
47%
Men
53%
Right
53%
Women
47%
A B
115Folia Neuropathologica 2015; 53/2
IgG4-related inflammatory orbital pseudotumors – a retrospective case series
cions of orbital locations of the disease were report-
ed in Japan as late as at the end of 2009. This find-
ing triggered the European studies on this subject 
[4]. The basic consensus of the diagnostic criteria 
for IgG4-related diseases was established in 2010. 
IgG4-related orbital disease may also be diagnosed 
by the presence of criteria proposed by Umehara 
et al. [37]. Patients with suspected IgG4-related orbit-
al disease may be assessed and diagnosed accord-
ing to either of these two sets of diagnostic criteria 
[37]. In 2010, Zen and Nakanuma demonstrated that 
IgG4-related disease symptoms may have different 
anatomical locations despite the same levels of IgG4 
in the studied tissues. This conclusion supports the 
Fig. 2. Comparison of IgG4+/CD138+ ratio (A) and IgG4+/IgG+ ratio (B) in pseudotumors and average patient 
age (C). In IgG4+, the IgG4+/CD138+ ratio is 10-50 while the IgG4+/IgG+ ratio is 40-70.
A
50
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20
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0
Ig
G
4+
/C
D
13
8+
PS
B C
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60
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0
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40
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0
Ig
G
4+
/I
gG
+
A
ge
PS PS
55.5
49.7
Table II. Detailed analysis of histopathological lesions in patients with histopathological diagnosis of orbital 
pseudotumor subjected to immunohistochemical screening for IgG4-related disease
Pseudotumor – IGG4+-related diseases
n FSS Cell infiltration Vascular changes
PLAS NEUT EOS TVL TBVW
1 +++ +++ – ++ ++ +
2 +++ ++ – ++ +++ ++
3 +++ +++ – +++ ++ ++
4 +++ +++ – +++ ++ +
5 ++ +++ – + + +
6 ++ +++ – + + +
7 +++ +++ +/– ++ +++ ++
8 +++ +++ – – ++ +
9 +++++ ++ – + +++ +++
10 +++ +++/++ – +++ ++ ++
11 +++ +++/++ – + ++ +
12 ++ +++/++ – + ++ +/–
13 ++ ++ +/– ++ ++
14 +++ +/– +/– +/– ++ ++
15 ++ +++ +/– +++ + –
16 ++ ++ +/– + + +
17 ++ ++ +/– + + +
Scale: − none, +/− sparse, + low, ++ medium, +++ high, +++++ very high 
FSS – fibrosis, PLAS − plasma cells, NEUT – neutrophils, EOS – eosinophils, TVL − thinning of the vascular lumen, TBVW − thickening of blood vessels walls
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IgG4 dependence of the disease [7,8]. IgG4-related 
orbital disease is a general term for the pathologies 
in the orbital region. Different orbital locations are 
possible. Most typically, the disease is diagnosed 
within the lacrimal gland (IgG4-related dacryoad-
enitis). This conclusion as drawn by other authors 
was also confirmed by the results of our study. 
The disease may also present as an IgG4-related 
orbital inflammatory pseudotumor or IgG4-related 
orbital myositis, which was also observed in the 
patients examined as part of this study.
To date, no such studies have been conducted 
in Poland. Examinations of such patients were ana-
lyzed both retrospectively and prospectively over the 
last 11 years to assess the possibility of IgG4-related 
orbital disease. The starting study population con-
sisted of 167 patients with isolated infiltrative tumor 
diseases within the orbital region treated at the ORL 
Clinic of the Jagiellonian University Medical College 
in Krakow. Of all the studied and analyzed patients, 
a  final group was selected to undergo diagnostic 
examinations for IgG4-related disease. The study 
group consisted of 17 patients with the diagnosis 
of pseudotumor lesions. According to the literature, 
the mean age for the established and probable cases 
of IgG4-related orbital disease is estimated at 55.5 
years [2]. The value was similar in our study, being 
49.6 years in the group of pseudotumor patients.
Fig. 3. Inflammatory orbital pseudotumor. A) Profuse lymphoplasmacytic infiltration of fibrous tissue. HE. 
40x. B) Clear positive immunohistochemical reaction to CD138 marking the plasma cells. 40x. C) Clear pos-
itive immunohistochemical reaction to IgG-positive cells – the reaction appears to be present in a higher 
number of cells than the reaction to CD138. However, it should be noted that IgG may also be produced 
by some B lymphocytes differentiating into plasma cells. 40x. D) Nearly all immunohistochemistry-marked 
plasma cells (CD138+) are IgG4-positive. 40x.
A B
C D
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Orbital pseudotumors are idiopathic inflammato-
ry processes occurring within the orbit and involving 
hypertrophy of fibrovascular tissue with low cellular 
polymorphism and lymphoplasmacytic infiltrations. 
Usually, orbital pseudotumors do not extend beyond 
the borders of the orbit, and their clinical course may 
be very diverse [21,22,25,40]. A total of 17 patients 
diagnosed with pseudotumors were selected from 
the population of non-malignant orbital lesion 
patients and subjected to diagnostic examinations 
for IgG4-related disease. The obtained results con-
firmed IgG4-related orbital disease. A  high degree 
of fibrosis was observed in histopathological spec-
imens, with numerous plasmacytic infiltrations con-
taining numerous eosinophils, up to 25 cells per field. 
Only isolated neutrophils were observed in about 
50% of cases. Vascular lesions (wall thickening and 
stenosis of tiny vessels of different intensity) were 
also observed in all cases; inflammatory thrombotic 
lesions were observed in three cases. Histopatholog-
ical lesions observed in the study material were very 
similar to those described by other authors [2]. What 
is important, in all patients diagnosed with pseudo-
tumors, the IgG4+/CD138+ ratio in orbital tissues was 
always more than 10%, and often as much as 40%. 
The IgG4+/IgG+ ratio was above 40% in all cases, and 
more than 80% in 3 patients. In all cases, fragments 
of lacrimal gland tissue and follicles were present in 
all histopathological specimens. As demonstrated by 
an increasing number of papers and confirmed by 
the results of this study, the tissue IgG4+/IgG+ ratio 
is the most important parameter for the diagnosed 
cases associated with IgG4+ plasma cells, and its 
value should be higher than 40% [7,8,36,39]. Other 
criteria, such as obliterated venous pattern with-
out the required inflammatory reaction or storiform 
fibrosis, are crucial for the diagnosis of IgG4-related 
disease [3,8,12,29,52,53]. In IgG4-related disease, 
the total number of IgG4-positive plasma cells must 
be elevated. It should be underlined that the study 
material was retrospective and has been analyzed 
several times.
Venous vessels are obliterated by profuse lympho- 
plasmacytic infiltration. Lymphocytes and plasma 
cells are present within both the vessel walls and 
the lumen. Partial obliteration of veins and inflam-
matory infiltration of the entire wall are also indic-
ative of IgG4-related disease. Lacrimal gland tissue 
was predominant in specimens analyzed at the Kra-
kow Clinic. Very high eosinophilic infiltration of up to 
20 cells per field of view was a characteristic feature 
of the specimens. According to worldwide litera-
ture, IgG4-related orbital disease is rarely associated 
with lymphoplasmacytic infiltration and eosinophilic 
material-containing macrophages [9]. In this aspect 
of IgG4-related disease, our results are in contrast to 
these findings. On the other hand, we confirmed the 
presence of microvascular lesions, reported to occur 
rarely for IgG4-related disease by other authors 
[9,26]. The clinical presentation usually excludes 
definite diagnosis. Most commonly, patients present 
at the laryngologist’s office with increasing orbital 
pain, impaired mobility of the eyeball and eyeball 
protrusion. In many cases, conjunctival edema and 
hyperemia, eyelid plethora and soft tissue edema 
were observed. Pain of the extraorbital muscle wall 
suggested a high likelihood of an orbital inflammato-
ry syndrome, particularly myositis. Visual acuity was 
impaired in cases of optic nerve or posterior sclera 
involvement. Sometimes, systemic symptoms, such 
as leukocytosis and fever, might indicate inflamma-
tion, which was consistent with observations made 
by other authors [3,21,22,25,27,40].
Biopsy is not required in all cases, as the clini-
cal and radiological presentation (including CT and 
MRI scans) may be sufficient to establish the diag-
nosis and start treatment. Other systemic disor-
ders that accompany IgG4-related disease include 
autoimmune pancreatitis, retroperitoneal fibrosis, 
mediastinal fibrosis, sclerosing cholangitis, Sjögren’s 
syndrome, xanthogranuloma, or inflammatory myo-
fibroblastic tumor [4]. The diagnostics of IgG4-related 
disease involves the use of intravenous gallium-67, 
which is accumulated at inflammation sites and, as 
evidenced by numerous studies of IgG4-related dis-
eases, is most commonly gathered within the lung 
tissue (hila) (77%) and the pancreas (76%). Gallium 
accumulation is also relatively common in salivary 
glands (54%), lacrimal glands (54%) and periaortal 
tissues (23%). Chronic inflammatory conditions that 
might obscure IgG4-related disease include: salivary 
tract inflammation, non-malignant oral lesions (e.g. 
cysts), gastrointestinal diseases (including Crohn’s 
disease and intestinal diverticulitis), synovitis, some 
malignant tumors (squamous cell carcinoma, ade-
noid cystic carcinoma), and numerous inflammatory 
skin diseases.
Each of the examined patients was subjected to 
CT and/or MRI scans before the scheduled surgery. 
On this basis, the appropriate treatment method and 
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surgical approach were determined. Detailed radio-
logical consultation was obtained, providing data to 
adopt a suitable treatment strategy. The entire man-
agement conducted at the Krakow Clinic of Otorhi-
nolaryngology suggests that the group of pseudotu-
mors is of a  very diverse character. Pseudotumors 
may resemble numerous other diseases, such as 
lymphoma, sarcoidosis, fibromatosis, and systemic 
connective tissue disorders (e.g. lupus erythemato-
sus and other granulomatous disorders), as was also 
reported in other studies [18,27,38]. 
The treatment and the outcomes in patients 
diagnosed with IgG4-related disease after one or 
more cycles of corticosteroids were different in 
female and male patients. IgG4-related orbital dis-
ease with the involvement of other organs may be 
considered a generalized disorder. The orbital loca-
tion may coexist with an extraorbital location [24]. 
Most commonly, extraorbital location is associated 
with the involvement of parotid glands and lymph 
nodes [5,11,14,15,29,30].
Positron emission tomography is an imaging 
examination that markedly facilitates the diagnosis 
of a systemic IgG4-related disease, both in cases dis-
tant from the orbit and in clinically silent IgG4-relat-
ed diseases [19]. Two such patients were identified 
in the study material, with generalized IgG4-related 
disease being confirmed by PET scans [9,24,35]. 
The consensus guidelines for histopathological 
diagnostics of IgG4-related orbital disease were pub-
lished at an international symposium in 2011 [7,8]. It 
was determined that IgG4-related disease is charac-
terized by different degrees of fibrosis and extensive 
lymphoplasmacytic infiltration of IgG4+ cells [7,8,33]. 
Lymphoplasmacytic infiltrations are more extensive 
at early stages of the disease and consist of poly-
clonal T cells, IgG4+ plasma cells and scattered eosin-
ophils. Subsequent biopsies conducted in a case of 
IgG4-related inflammation of lacrimal ducts revealed 
increased fibrosis. The process has been proposed as 
the natural history of the disease which, when accu-
mulated, in the fibrosis stage [5,10]. However, some 
diseases may originate from a primary sclerotic pro-
cess. The histopathological image of IgG4-related 
orbital disease includes lymphoplasmacytic infiltra-
tion of various degree with predominant fibrosis 
or reactive lymphoid hyperplasia [14,15,26,29,36]. 
IgG4-related orbital disease may involve infiltra-
tions of lymphoplasma cells, macrophages, as well 
as eosinophils [14,15]. The clinical material in this 
study was characterized by significant differences in 
the histopathological image compared to that pre-
sented by other authors. A characteristic trait in the 
histological presentation of IgG4-related disease is 
the presence of thromboangiitis obliterans, very rare 
in orbital IgG4-related disease [16,17,26]. The patho-
genesis of the disease may include the immune 
response to an antigen within the upper segment 
of the respiratory/alimentary tract. Nosocomial enti-
ties currently identified as IgG4-related diseases 
include numerous disorders of heterogeneous clini-
cal presentations, previously listed as separate and 
unrelated entities [13]. IgG4-related disease should 
be suspected on the basis of the presence of one 
of the accompanying symptoms, such as symmet-
rical swelling of lacrimal or salivary glands, autoim-
mune pancreatitis, inflammatory orbital pseudotu-
mor, retroperitoneal fibrosis, lymphadenopathies, 
or Castleman’s disease. The results presented in 
this study are in agreement with the conclusions of 
the panel of experts gathered in Boston in 2011 to 
present the “Consensus statement on the pathology 
of IgG4-related disease” [7,8]. The comprehensive 
diagnostic criteria proposed by Umehara et al. in 
2012 provided a breakthrough in the establishment 
of IgG4-related orbital disease as a unique nosoco-
mial entity; however, some details require further 
elucidation. The authors did not report on the size of 
the large magnification field to be used when count-
ing IgG4-positive cells. IgG4-related orbital disease is 
a general term for pathologies in the orbital region. 
Different orbital locations are possible. Most typical-
ly, the disease is diagnosed within the lacrimal gland 
(IgG4-related dacryoadenitis); it may also present as 
an IgG4-related orbital inflammatory pseudotumor 
or IgG4-related orbital myositis. Serum IgG4 level is 
considered to be a  less valuable diagnostic marker 
compared to the tissue IgG4 content and is usually 
elevated by 40% with biopsy-confirmed IgG4-relat-
ed disease [28]. Recent results suggest that it is the 
ratio between serum IgG4 and IgG, rather than the 
levels themselves, that is important, as the serum 
levels themselves may be within the normal range. 
According to recent international studies [19,20] 
the serum IgG4+/IgG+ ratio of 5-10% may be a sen-
sitive and specific marker indicative of early and 
single organ-limited development of an IgG4-related 
disease. Having analyzed the results of histopatho-
logical assays and serum IgG and IgG4 level tests, 
the researchers observed significantly elevated 
119Folia Neuropathologica 2015; 53/2
IgG4-related inflammatory orbital pseudotumors – a retrospective case series
serum IgG4 levels in only one case of bilateral orbit-
al pseudotumor. The remaining results were within 
the normal laboratory range for IgG4 levels while 
being at the limit of the range in only 2 cases of 
orbital pseudotumors (single-sided). Despite the fact 
that the blood levels of IgG and IgG4 were normal, 
the analysis of the IgG4+/IgG+ ratio revealed a value 
of above 8%, indicative of possible development of 
an IgG4-related disease limited to a single organ, as 
suggested by Masaki et al. in their article published 
in 2012. Such results were observed in 3 of the diag-
nosed patients in whom pseudotumors were shown 
to be associated with elevated IgG4 levels in orbital 
tissues. 
Idiopathic orbital inflammation poses a  signif-
icant challenge to therapists and is characterized 
by a tendency to recur in more than 50% of cases 
[16,17]. The treatment is empirical in nature, as the 
pathophysiology of the disease has not been fully 
explained. Clinical treatment involves administra-
tion of corticosteroids. Physicians are often left with 
symptomatic treatment as the only option, including 
suppression of inflammation with corticosteroids. 
Identification of IgG4-related orbital diseases is 
important as lesions may be very sensitive to target-
ed biological treatment [13]. Unfortunately, no pro-
spective clinical studies are available with regard to 
IgG4-related disease, with treatment methods being 
based on retrospective observations in relatively 
small patient groups. Before initiating treatment, it 
is important to establish the histopathological diag-
nosis and exclude possible malignancy [10]. Rituxi- 
mab, a  monoclonal anti-CD20 antibody, was used 
against B cells. Rapid reduction in blood IgG4 levels 
was observed in patients who received the drug [6]. 
Thus, modulation of B cell function led to a change 
in interactions between B cells and plasma cells, 
affording good therapeutic effects. Currently, a che-
motherapeutic agent, bortezomib, is also in use.
To sum up, IgG4-related disease is most com-
monly manifested by a tumorous mass in the affect-
ed organ. Correct presurgical screening for IgG4-re-
lated disease may allow major orbital procedures to 
be avoided in some patients. Identification of typical 
histopathological lesions, particularly infiltrations of 
IgG4-positive plasma cells, remains the gold stan-
dard for establishing a  correct diagnosis. Although 
an increased serum IgG level is neither sufficient nor 
necessary to diagnose IgG4-related disease, it may 
be helpful in the diagnostic process.
Disclosure
The authors report no conflict of interest.
References
1. Alinari L, Castellucci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, 
Berkowitz A, Tani M, Farsad M, Franchi R, Fanti S, Zinzani PL. 
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) 
lymphoma. Leuk Lymphoma 2006; 47: 2096-2101.
2. Andrew N, Kearney D, Selva D. IgG4-related orbital disease: 
a meta-analysis and review. Acta Ophthalmol 2012; 11: 1-7.
3. Aznabaev MT, Gabdrakhmanova AF, Gaĭsina GF. Comprehen-
sive ultrasound diagnosis of orbital tumors and pseudotumors. 
Vestn Oftalmol 2006; 122: 7-9.
4. Benlemlih A, Szableski V, Bendahou M, Rivière S, Villain M, 
Costes V. Eosinophilic angiocentric fibrosis: A form of IgG4- 
related systemic disease. Ann Pathol 2012; 32: 271-275.
5. Cheuk W. Chronic sclerosing dacryoadenitis: part of the spec-
trum of IgG4-related sclerosing disease. Am J Surg Pathol 2007; 
31: 643-645.
6. Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Pec-
catori F, Ponzoni M, Pedrinis E, Dell’Oro S, Pruneri G, Filipazzi V, 
Dietrich PY, Gianni AM, Coiffier B, Cavalli F, Zucca E. Clinical 
activity of rituximab in extranodal marginal zone B-cell lym-
phoma of MALT type. Blood 2003; 102: 2741-2745.
7. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, 
Heathcote JG, Khosroshahi A, Ferry JA, Aalberse RC, Bloch DB, 
Brugge WR, Bateman AC, Carruthers MN, Chari ST, Cheuk W, 
Cornell LD, Fernandez-Del Castillo C, Forcione DG, Hamilos DL, 
Kamisawa T, Kasashima S, Kawa S, Kawano M, Lauwers GY, 
Masaki Y, Nakanuma Y, Notohara K, Okazaki K, Ryu JK, Saeki T, 
Sahani DV, Smyrk TC, Stone JR, Takahira M, Webster GJ, Yama-
moto M, Zamboni G, Umehara H, Stone JH. Consensus state-
ment on the pathology of IgG4-related disease. Mod Pathol 
2012; 25: 1181-1192.
8. Deshpande V. The pathology of IgG4-related disease: critical 
issues and challenges. Semin Diagn Pathol 2012; 29: 191-196.
9. Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rub-
bia-Brandt L, Lauwers GY. IgG4-associated cholangitis: a com-
parative histological and immunophenotypic study with prima-
ry sclerosing cholangitis on liver biopsy material. Mod Pathol 
2009; 22: 1287-1295.
10. Divatia M, Kim SA, Ro JY. IgG4-related sclerosing disease, an 
emerging entity: a review of a multi-system disease. Yonsei 
Med J 2012; 53: 15-34.
11. Gayed I, Eskandari MF, McLaughlin P, Pro B, Diba R, Esmaeli B. 
Value of positron emission tomography in staging ocular 
adnexal lymphomas and evaluating their response to therapy. 
Ophthalmic Surg Lasers Imaging 2007; 38: 319-325.
12. Go H, Kim JE, Kim YA, Chung HK, Khwarg SI, Kim CW, Jeon YK. 
Ocular adnexal IgG4-related disease: comparative analysis 
with mucosa-associated lymphoid tissue lymphoma and other 
chronic inflammatory conditions. Histopathology 2012; 60: 
296-312.
13. Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, 
Amemiya K, Egawa N, Nakajima H. Close relationship between 
120 Folia Neuropathologica 2015; 53/2
Krzysztof Oles, Wojciech Szczepanski, Jacek Skladzien, Krzysztof Okon, Joanna Leszczynska, Emilia Bojanowska, Magdalena Bialas,  
Agnieszka Wrobel, Joanna Mika
autoimmune pancreatitis and multifocal fibrosclerosis. Gut 
2003; 52: 683-687.
14. Khosroshahi A, Stone JH. A clinical overview of IgG4-related 
systemic disease. Curr Opin Rheumatol 2011; 23: 57-66.
15. Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnex-
al IgG4-related lymphoplasmacytic infiltrative disorder. Arch 
Ophthalmol 2010; 128: 577-584.
16. Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H. Ocular 
adnexal marginal zone B cell lymphoma infiltrated by IgG4- 
positive plasma cells. J Clin Pathol 2010; 63: 1059-1065.
17. Lindfield D, Attfield K, McElvanney A. Systemic immunoglobulin 
G4 (IgG4) disease and idiopathic orbital inflammation; remov-
ing ‘idiopathic’ from the nomenclature? Eye (Lond) 2012; 26: 
623-629.
18. Lindfield D. Rituximab in IgG4-related inflammatory disease of 
the orbit and ocular adnexae. Eye (Lond) 2012; 26: 1386.
19. Mafee MF, Karimi A, Shah JD, Rapoport M, Ansari SA. Anatomy 
and pathology of the eye: role of MR imaging and CT. Magn 
Reson Imaging Clin N Am 2006; 14: 249-270.
20. Masaki Y, Kurose N, Umehara H. IgG4-related disease: a nov-
el lymphoproliferative disorder discovered and established in 
Japan in the 21st century. J Clin Exp Hematop 2011; 51: 13-20.
21. Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azu-
mi A, Nakada S, Matsui S, Origuchi T, Nishiyama S, Yamada K, 
Kawano M, Hirabayashi A, Fujikawa K, Sugiura T, Horikoshi M, 
Umeda N, Minato H, Nakamura T, Iwao H, Nakajima A, Miki M, 
Sakai T, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, 
Eguchi K, Sugai S, Umehara H. Cutoff Values of Serum IgG4 and 
Histopathological IgG4+ Plasma Cells for Diagnosis of Patients 
with IgG4-Related Disease. Int J Rheumatol 2012; 2012: 580814.
22. Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. 
What is orbital pseudotumor? Surv Ophthalmol 1996; 41: 
66-78.
23. Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef 
L. Are systemic corticosteroids useful in the management of 
orbital pseudotumors? Ophthalmology 1996; 103: 521-528.
24. Nemec SF, Peloschek P, Schmook MT, Krestan CR, Hauff W, Ma- 
tula C, Czerny C. CT-MR image data fusion for computer-assist-
ed navigated surgery of orbital tumors. Eur J Radiol 2010; 73: 
224-229.
25. Pasquali T, Schoenfield L, Spalding SJ, Singh AD. Orbital inflam-
mation in IgG4-related sclerosing disease. Orbit 2011; 30: 258-
260.
26. Pemberton JD, Fay A. Idiopathic sclerosing orbital inflamma-
tion: a review of demographics, clinical presentation, imaging, 
pathology, treatment, and outcome. Ophthal Plast Reconstr 
Surg 2012; 28: 79-83.
27. Plaza JA, Garrity JA, Dogan A, Ananthamurthy A, Witzig TE, 
Salomão DR. Orbital inflammation with IgG4-positive plasma 
cells: manifestation of IgG4 systemic disease. Arch Ophthalmol 
2011; 129: 421-428.
28. Rootman J, McCarthy M, White V, Harris G, Kennerdell J. Idio-
pathic sclerosing inflammation of the orbit. A distinct clinico-
pathologic entity. Ophthalmology 1994; 101: 570-584.
29. Sah RP, Chari ST. Serologic issues in IgG4-related systemic dis-
ease and autoimmune pancreatitis. Curr Opin Rheumatol 2011; 
23: 108-113.
30. Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, 
Takata K, Morito T, Kondo E, Yoshino T. Ocular adnexal IgG4- 
related disease has uniform clinicopathology. Pathol Int 2008; 
58: 465-470.
31. Sato Y, Ohshima K, Takata K, Huang X, Cui W, Ohno K, Yoshino T. 
Ocular adnexal IgG4-producing mucosa-associated lymphoid 
tissue lymphoma mimicking IgG4-related disease. J Clin Exp 
Hematop 2012; 52: 51-55.
32. Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, 
Mizobuchi K, Fujihara M, Kuraoka K, Nakai T, Ichimura K, Tana-
ka T, Tamura M, Nishikawa Y, Yoshino T. Systemic IgG4-related 
lymphadenopathy: a clinical and pathologic comparison to 
multicentric Castleman’s disease. Mod Pathol 2009; 22: 589-
599.
33. Shrestha B, Sekiguchi H, Colby TV, Graziano P, Aubry MC, Smyrk TC, 
Feldman AL, Cornell LD, Ryu JH, Chari ST, Dueck AC, Yi ES. Dis-
tinctive pulmonary histopathology with increased IgG4-pos-
itive plasma cells in patients with autoimmune pancreatitis: 
report of 6 and 12 cases with similar histopathology. Am J Surg 
Pathol 2009; 33: 1450-1462.
34. Smyrk TC. Pathological features of IgG4-related sclerosing dis-
ease. Curr Opin Rheumatol 2011; 23: 74-79.
35. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plas-
ma cells are ubiquitous in diverse localised non-specific chron-
ic inflammatory conditions and need to be distinguished from 
IgG4-related systemic disorders. J Clin Pathol 2011; 64: 237-243.
36. Suga K, Kawakami Y, Hiyama A, Hori K, Takeuchi M. F-18 FDG 
PET-CT findings in Mikulicz disease and systemic involvement 
of IgG4-related lesions. Clin Nucl Med 2009; 34: 164-167.
37. Takahira M, Kawano M, Zen Y, Minato H, Yamada K, Sugiyama K. 
IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthal-
mol 2007; 125: 1575-1578.
38. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, 
Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, 
Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, 
Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, 
Hibi T, Tsubouchi H, Inui K, Ohara H. Comprehensive diagnos-
tic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol 
2012; 22: 21-30.
39. Weber AL, Romo LV, Sabates NR. Pseudotumor of the orbit. Clin-
ical, pathologic, and radiologic evaluation. Radiol Clin North 
Am 1999; 37: 151-168.
40. Winn BJ, Rootman J. Sclerosing orbital inflammation and sys-
temic disease. Ophthal Plast Reconstr Surg 2012; 28: 107-118.
41. Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, Nami-
ki M, Kasashima S, Kawashima A, Matsumoto Y, Katayanagi K, 
Murata T, Ishizawa S, Hosaka N, Kuriki K, Nakanuma Y. Retro-
peritoneal fibrosis: a clinicopathologic study with respect to 
immunoglobulin G4. Am J Surg Pathol 2009; 33: 1833-1839.
42. Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional 
study of 114 cases. Am J Surg Pathol 2010; 34: 1812-1819.
